Document is current
Any future updates will be listed below
-
Authors
Setayesh, Sonia Maryam
Hart, Olivia
Naghdloo, Amin
Higa, Nikki
Nieva, Jorge
Lu, Janice
Hwang, Shelley
Wilkinson, Kathy
Kidd, Michael
Anderson, Amanda http://orcid.org/0000-0001-7686-7477
Velasco, Carmen Ruiz
Kolatkar, Anand http://orcid.org/0000-0002-8621-1073
Matsumoto, Nicholas
Nevarez, Rafael
Hicks, James B. http://orcid.org/0000-0001-5353-4338
Mason, Jeremy http://orcid.org/0000-0002-5933-5003
Shishido, Stephanie N.
Kuhn, Peter http://orcid.org/0000-0003-2629-4505
-
Funding
Funding for this research was provided by:
Breast Cancer Research Foundation (BCRF-20-089, BCRF-20-089)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (HHSN261200800001E, HHSN261200800001E)
Winnie and James Hart Endowed Fellowship, 2021
USC Dornsife Student Opportunities for Academic Research Fellowship, 2021
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Kalayil and Leela Chacko, M.D. Fellowship
- License Information
-
More Information
Article History
Received: 19 November 2021
Accepted: 16 September 2022
First Online: 27 September 2022
Competing interests
: The authors declare no competing non-financial interest but the following Financial Competing Interests for Carmen Ruiz Velasco: Inventor receiving royalties on patent licensed to Epic Sciences, Inc.; Anand Kolatkar: receiving stock and royalties, Epic Sciences, Inc., Nicholas Matsumoto: Inventor receiving royalties on patent licensed to Epic Sciences, Inc.; Rafael Nevarez: Inventor receiving royalties on patent licensed to Epic Sciences, Inc.; James B. Hicks: is an unpaid consultant/member on the Clinical Advisory Board, Epic Sciences, Inc.; Peter Kuhn: founder and Chief Scientific Advisor, and received stock and receiving dividends, Epic Sciences, Inc. The rest of the Authors declare no Financial Competing Interests.
